Nantahala Capital Management, LLC - Feb 3, 2025 Form SCHEDULE 13D/A Schedule Report for EVOKE PHARMA, INC. (EVOK)

Reporting Manager
Nantahala Capital Management, LLC
Symbol
EVOK
Shares outstanding
1.59M shares
Disclosed Ownership
255K shares
Ownership
16%
Form type
SCHEDULE 13D/A
Date filed
2/3/2025, 04:47 PM
Date of event
Feb 3, 2025

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 15.99% 255K 0 255K /s/ Taki Vasilakis Taki Vasilakis/Chief Compliance Officer 0001472322
Wilmot B. Harkey 15.99% 255K 0 255K /s/ Wilmot B. Harkey Wilmot B. Harkey/Manager
Daniel Mack 15.99% 255K 0 255K /s/ Daniel Mack Daniel Mack/Manager